Two women have come forward with accounts of drug-facilitated sexual assault (DFSA), highlighting the complex and often overlooked nature of this form of abuse within intimate relationships. Their stories underscore challenges faced by survivors in recognizing the crime, obtaining support, and navigating the criminal justice system.

Zoe Watts, who was married for 14 years and together with her husband for 18, revealed that her husband had been secretly adding sedatives to her tea before sexually assaulting her and filming the abuse over an extended period. Watts only became aware of the situation in early 2018 after her husband disclosed the acts following a church service. She described the experience as shattering, emphasizing that the trauma deeply undermined her sense of safety within the family, as the abuse took place within the marriage and involved betrayal on multiple levels. Watts recounted physical symptoms she had endured for years—including recurrent infections, fatigue, confusion, and migraines—which she later connected to the drugging. Despite visiting medical professionals and even accompanying her husband to doctor’s appointments, the full extent of the abuse went unrecognized for a significant time, reflecting broader gaps in understanding drug-facilitated assault. Watts has since become an advocate for greater awareness of DFSA, stressing the importance of recognizing signs and building specialized support services for survivors.

The police reportedly treated Watts’s report seriously, and although she initially doubted whether what had happened to her constituted rape, officers clarified that sedation negates consent. Despite this, the Crown Prosecution Service (CPS) initially opted not to charge her husband, a decision Watts contested through persistent communication. When charges were eventually brought forward, her husband was found guilty in 2022 of rape, assault by penetration, and administering a substance to overpower her. Watts noted that even after the conviction, some community members remained supportive of her husband, reflecting the stigma and disbelief often faced by survivors.

Another case involves a woman named Stanhope, who met her abuser, Rogerson, in 2019. Their relationship quickly escalated but became marked by controlling behavior and abuse. Stanhope was prescribed various medications, including antidepressants and antipsychotics, as she experienced confusion, memory loss, and symptoms initially misdiagnosed as pseudo-dementia. Stanhope later connected these symptoms to her partner’s abuse, including drugging and sexual assaults that often occurred while she was unconscious. She described persistent gaslighting that caused her to doubt her own perceptions for years. Rogerson’s actions were revealed in part after he raped her while awaiting ambulance paramedics following her suicide attempt. Although Rogerson was charged with multiple counts of rape unrelated to DFSA—since Stanhope had knowingly taken medication—police investigations found he had filmed an assault and posted images online. Rogerson died by suicide six weeks after his arraignment.

Both women’s experiences highlight the difficulties in identifying DFSA, particularly when the perpetrator is a trusted partner and the victim is incapacitated by drugs. Medical professionals, law enforcement, and legal authorities have historically struggled to categorize such cases appropriately, often failing to provide adequate support or recognition. Survivors report a lack of specialized services addressing the unique trauma of DFSA, contributing to feelings of isolation. These accounts contribute to a growing discourse on the need for increased public awareness, improved medical assessment protocols, and legal frameworks that acknowledge the nuances of consent under sedation.

Their testimonies underscore a broader call to dismantle misconceptions surrounding sexual assault within relationships, particularly forms that remain hidden due to sedation and the manipulation of trust.